Literature DB >> 26200226

Sex dimorphism in periodontitis in animal models.

X Duan2, R C Gleason2, F Li2, K B Hosur3, X Duan2, D Huang1, H Wang2, G Hajishengallis3, S Liang2.   

Abstract

BACKGROUND AND
OBJECTIVE: Although surveys in the USA have shown that male subjects are more prone to develop periodontitis, sex as a risk factor in periodontitis, and its mechanism, remain controversial. Animal models are ideal for investigating immunological mechanisms of sex dimorphism in periodontitis because in these models it is possible to exclude the interference of gender-related risk factors, such as smoking and oral hygiene habits. Based on surveys in humans and reports on sex dimorphism in other diseases, our hypothesis is that sex is a risk factor in periodontitis.
MATERIAL AND METHODS: Different murine models (oral gavage model and ligature model) for periodontitis have been utilized to determine susceptibility to periodontitis in female and male mice. Periodontal bone levels were measured as the distance from the cemento-enamel junction to the alveolar bone crest (CEJ-ABC) in young female or male mice (8-10 wk of age). Differential expression of inflammatory mediators in the gingivae of female and male mice was determined by quantitative real-time PCR.
RESULTS: In comparison with male mice, female mice displayed significantly (p < 0.05) increased periodontal bone loss, accompanied by elevated expression of proinflammatory cytokines (interleukin-1β, interleukin-6 and interleukin-17A) and higher numbers of oral bacteria.
CONCLUSION: In contrast to the results in humans, in which periodontitis susceptibility is also influenced by confounding gender-related behaviors, in the murine oral gavage model and ligature model, female mice appear to be more susceptible to periodontal bone loss than male mice. In the ligature model, we observed significantly (p < 0.05) higher CEJ-ABC distance, gingival proinflammatory cytokine production and number of oral bacteria in female mice. Furthermore, our results imply that female mice develop periodontitis with a higher progression rate. Our study has therefore established that animal models can be used to dissect the mechanisms underlying genuine gender-based differences in periodontal disease susceptibility and/or progression.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  alveolar bone loss; animal model; gingival inflammation; periodontal disease; risk factor

Mesh:

Substances:

Year:  2015        PMID: 26200226      PMCID: PMC4723298          DOI: 10.1111/jre.12298

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  29 in total

1.  Risk of severe periodontal disease in a Swedish adult population. A longitudinal study.

Authors:  O Norderyd; A Hugoson; G Grusovin
Journal:  J Clin Periodontol       Date:  1999-09       Impact factor: 8.728

Review 2.  Position paper: epidemiology of periodontal diseases.

Authors:  Brian Burt
Journal:  J Periodontol       Date:  2005-08       Impact factor: 6.993

Review 3.  IL-17 family cytokines and the expanding diversity of effector T cell lineages.

Authors:  Casey T Weaver; Robin D Hatton; Paul R Mangan; Laurie E Harrington
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

Review 4.  Periodontal diseases.

Authors:  Bruce L Pihlstrom; Bryan S Michalowicz; Newell W Johnson
Journal:  Lancet       Date:  2005-11-19       Impact factor: 79.321

5.  IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis.

Authors:  R Assuma; T Oates; D Cochran; S Amar; D T Graves
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

6.  Tumour necrosis factor alpha in gingival crevicular fluid as a possible indicator of periodontal disease in humans.

Authors:  E F Rossomando; J E Kennedy; J Hadjimichael
Journal:  Arch Oral Biol       Date:  1990       Impact factor: 2.633

7.  CD4(+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice.

Authors:  P J Baker; M Dixon; R T Evans; L Dufour; E Johnson; D C Roopenian
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

Review 8.  Current view of risk factors for periodontal diseases.

Authors:  R J Genco
Journal:  J Periodontol       Date:  1996-10       Impact factor: 6.993

9.  Measurement of interleukin-1 alpha and -1 beta in gingival crevicular fluid: implications for the pathogenesis of periodontal disease.

Authors:  M P Masada; R Persson; J S Kenney; S W Lee; R C Page; A C Allison
Journal:  J Periodontal Res       Date:  1990-05       Impact factor: 4.419

10.  Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice.

Authors:  P J Baker; R T Evans; D C Roopenian
Journal:  Arch Oral Biol       Date:  1994-12       Impact factor: 2.633

View more
  5 in total

1.  MicroRNA-21 down-regulates inflammation and inhibits periodontitis.

Authors:  Wei Zhou; Li Su; Xingyu Duan; Xi Chen; Aislinn Hays; Satya Upadhyayula; Juili Shivde; Huizhi Wang; Yong Li; Dingming Huang; Shuang Liang
Journal:  Mol Immunol       Date:  2018-06-06       Impact factor: 4.407

2.  The optimization of ligature/bone defect-induced periodontitis model in rats.

Authors:  Jingyi Gao; Simin Cai; Zijie Wang; Dan Li; Minyi Ou; Xinlu Zhang; Zhihui Tian
Journal:  Odontology       Date:  2022-06-03       Impact factor: 2.885

Review 3.  Polymicrobial communities in periodontal disease: Their quasi-organismal nature and dialogue with the host.

Authors:  George Hajishengallis; Richard J Lamont
Journal:  Periodontol 2000       Date:  2021-03-10       Impact factor: 12.239

4.  The Sex and Gender Intersection in Chronic Periodontitis.

Authors:  Effie Ioannidou
Journal:  Front Public Health       Date:  2017-08-04

5.  O-Polysaccharide Plays a Major Role on the Virulence and Immunostimulatory Potential of Aggregatibacter actinomycetemcomitans During Periodontal Infection.

Authors:  Gustavo Monasterio; Francisca Castillo; Jessica Astorga; Anilei Hoare; Claudia Terraza-Aguirre; Emilio A Cafferata; Eduardo J Villablanca; Rolando Vernal
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.